Literature DB >> 4400295

Glutamic acid as a precursor to N-terminal pyroglutamic acid in mouse plasmacytoma protein (protein synthesis-initiation-immunoglobulins-pyrrolidone carboxylic acid).

D R Twardzik, A Peterkofsky.   

Abstract

Cell suspensions derived from a mouse plasmacytoma (RPC-20) that secretes an immunoglobulin light chain containing N-terminal pyroglutamic acid can synthesize protein in vitro. Chromatographic examination of an enzymatic digest of protein labeled with glutamic acid shows only labeled glutamic acid and pyroglutamic acid; hydrolysis of protein from cells labeled with glutamine, however, yields substantial amounts of glutamic acid in addition to glutamine and pyroglutamic acid. The absence of glutamine synthetase and presence of glutaminase in plasmacytoma homogenates is consistent with these findings. These data indicate that N-terminal pyroglutamic acid can be derived from glutamic acid without prior conversion of glutamic acid to glutamine. Since free or bound forms of glutamine cyclize nonezymatically to pyroglutamate with ease, while glutamic acid does not, the data suggest that N-terminal pyroglutamic acid formation from glutamic acid is enzymatic rather than spontaneous.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4400295      PMCID: PMC427590          DOI: 10.1073/pnas.69.1.274

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  8 in total

1.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

2.  Nutrition needs of mammalian cells in tissue culture.

Authors:  H EAGLE
Journal:  Science       Date:  1955-09-16       Impact factor: 47.728

3.  Pyrrolid-2-one-5 carboxylic acid involvement in the biosynthesis of rabbit immunoglobulin.

Authors:  B Moav; T N Harris
Journal:  Biochem Biophys Res Commun       Date:  1967-12-15       Impact factor: 3.575

4.  The role of pyrrolidone carboxylic acid in the initiation of immunoglobulin peptide chains.

Authors:  C Baglioni
Journal:  Biochem Biophys Res Commun       Date:  1970-01-23       Impact factor: 3.575

5.  The indirect incorporation of pyrrolidone carboxylic acid into transfer ribonucleic acid.

Authors:  E A Rush; J L Starr
Journal:  Biochim Biophys Acta       Date:  1970-01-21

6.  N-formylmethionyl-sRNA as the initiator of protein synthesis.

Authors:  J M Adams; M R Capecchi
Journal:  Proc Natl Acad Sci U S A       Date:  1966-01       Impact factor: 11.205

7.  In vitro protein synthesis: chain initiation.

Authors:  R E Webster; D L Engelhardt; N D Zinder
Journal:  Proc Natl Acad Sci U S A       Date:  1966-01       Impact factor: 11.205

8.  A radiochemical assay for glutamine synthetase, and activity of the enzyme in rat tissues.

Authors:  P Lund
Journal:  Biochem J       Date:  1970-06       Impact factor: 3.857

  8 in total
  4 in total

1.  HCF-1 is cleaved in the active site of O-GlcNAc transferase.

Authors:  Michael B Lazarus; Jiaoyang Jiang; Vaibhav Kapuria; Tanja Bhuiyan; John Janetzko; Wesley F Zandberg; David J Vocadlo; Winship Herr; Suzanne Walker
Journal:  Science       Date:  2013-12-06       Impact factor: 47.728

Review 2.  Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal.

Authors:  G N Abraham; D N Podell
Journal:  Mol Cell Biochem       Date:  1981-08-11       Impact factor: 3.396

3.  Glutamine as a precursor to N-terminal pyrrolid-2-one-5-carboxylic acid in mouse immunoglobulin lambda-type light chains. Amino acid-sequence variability at the N-terminal extra piece of lambda-type light-chain precursors.

Authors:  Y Burstein; I Schechter
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

4.  Purification and Characterization of Recombinant N-Terminally Pyroglutamate-Modified Amyloid-β Variants and Structural Analysis by Solution NMR Spectroscopy.

Authors:  Christina Dammers; Lothar Gremer; Philipp Neudecker; Hans-Ulrich Demuth; Melanie Schwarten; Dieter Willbold
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.